Intravascular brachytherapy: Indications and management of adverse events

American Journal of Cardiovascular Drugs

Volumn 4, Issue 6, 2004, Pages 385-394

  Bhargava, Balram ^a   Karthikeyan, Ganesan ^a   Tripuraneni, Prabhakar ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; IRIDIUM 192; PHOSPHORUS 32; STRONTIUM 90; YTTRIUM 90;

ANGIOCARDIOGRAPHY; BRACHYTHERAPY; CLINICAL TRIAL; CORONARY STENT; DEVICE; DOSIMETRY; FEASIBILITY STUDY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SAPHENOUS VEIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VEIN GRAFT;

BETA RAYS; BRACHYTHERAPY; CORONARY RESTENOSIS; CORONARY STENOSIS; GAMMA RAYS; HUMANS; PERIPHERAL VASCULAR DISEASES; RANDOMIZED CONTROLLED TRIALS; STENTS; THROMBOSIS;

EID: 10444237236     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200404060-00007     Document Type: Review

References (62)

1. Casterella PJ. Restenosis: the scope of the problem. In: Tripuraneni P, Jani S, Minar E, et al., editors. Intravascular brachytherapy: from theory to practice. London: Remedica Publishing, 2001: 143-65
2. Condado JA, Waksman R, Gurdiel O. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96: 727-32
3. Condado JA, Waksman R, Calderas C. Two-year follow-up after intracoronary gamma radiation therapy. Cardiovasc Radiat Med 1999; 1 (1): 30-5
4. Condado JA, Waksman R, Saucedo JF, et al. Five-year clinical and angiographic follow-up after intracoronary iridium-192 radiation therapy. Cardiovasc Radiat Med 2002; 3: 74-81
5. Verin V, Urban P, Popowski Y, et al. Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. Circulation 1997; 95: 1138-44
6. Verin V, Popowski Y. Intraarterial beta irradiation to reduce restenosis after PTCA: experimental and clinical experience. Herz 1998; 6: 347-55
7. Teirstein PS, Masullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336: 1697-703
8. Teirstein PS, Masullo V, Jani S, et al. A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial. Int J Radiat Oncol Biol Phys 1998; 42: 1097-104
9. Teirstein PS, Masullo V, Jani S, et al. Two-year follow-up after catheter based radiotherapy to inhibit coronary restenosis. Circulation 1999; 99: 243-7
10. Teirstein PS, Masullo V, Jani S, et al. Three-year clinical and angiographic follow-up after coronary radiation: results of a randomized clinical trial. Circulation 2000; 101: 360-5
11. Leon MB, Teirstein PS, Moses JW. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344 (4): 250-6
12. Tripuraneni P. Coronary artery radiation therapy for the prevention of restenosis after percutaneous coronary angioplasty II: outcomes of clinical trials. Semin Radiat Oncol 2002; 12: 17-30
13. Kuntz R. De novo Betacath system trial (BETACATH). 50th Annual Scientific Session of the American College of Cardiology; 2001 Mar 18-21; Orlando
14. Waksman R, Laird JR, Jurkovitz CT, et al. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility trial. Peripheral Artery Radiation Investigational Study (PARIS) investigators. J Vasc Interv Radiol 2001; 12: 915-21
15. 90Sr/Y beta radiation for the treatment of in-stent restenosis. J Am Coll Cardiol 2000; 36: 311-2
16. Waksman R, Raizner AE, Yeung AC, et al. Use of localized intracoronary β radiation in the treatment of instent restenosis: the INHIBIT randomized controlled trial. Lancet 2002; 359 (9306): 551-7
17. Sapirstein W, Zuckerman B, Dillard J. FDA approval of coronary artery brachytherapy. N Engl J Med 2001; 344 (4): 297-9
18. Albiero R, Colombo A. Radiation therapy in coronary arteries: radioactive stent trials. In: Tripuraneni P, Jani S, Minar E, et al., editors. Intravascular brachytherapy: from theory to practice. London: Remedica Publishing, 2001: 215-24
19. Waksman R, Serruys PW, editors. Handbook of vascular brachytherapy. 2nd ed. London: Martun Dunitz Ltd, 2000
20. Waksman R, White L, Chan R, et al. Intracoronary beta-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000; 101: 2165-71
21. Tripuraneni P, Leon MB, Teirstein PS, et al. Gamma II, a prospective multicenter registry, with fixed dosing regimen compared to the gamma I trial, using IR-192 in the treatment of coronary treatment of coronary in-stent restenosis [abstract]. Int J Radiat Oncol Biol Phys 2000; 48 (3): 144
22. Waksman R, Cheneau E, Ajani AE, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) studies. Circulation 2003; 107: 1744-9
23. Waksman R, Ajani AE, White RL, Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6-months of Clopidogrel (WRIST PLUS). Circulation 2001; 103 (19): 2332-5
24. Sanfilippo NJ, Tripuraneni P. Intravascular brachytherapy trials for coronary heart disease using gamma sources. Front Radiat Ther Oncol 2001; 35: 202-10
25. Waksman R, Bhargava B, Porazzo M, et al. Intracoronary radiation with gamma wire inhibits recurrence of instent restenosis. Cardiovasc Radiat Med 2001 Apr-Jun; 2 (2): 63-68
26. Bhargava B, Tripuraneni P. Role of intracoronary brachytherapy for in-stent restenosis? Lancet 2002; 359 (9306): 543-4
27. Suntharalingam M, Laskey W, Lansky AJ, et al. Clinical and angiographic outcomes after use of 90strontium/90yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002; 52: 1075-82
28. Raizner AE, Oesterle SN, Waksman R. Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular ENergy Trial (PREVENT). Circulation 2000; 102 (9): 951-8
29. Waksman R, Buchbinder M, Reisman M, et al. Balloon-based radiation therapy for treatment of in-stent restenosis in human coronary arteries: results from the BRITE I study. Catheter Cardiovasc Interv 2002; 57: 286-94
30. Waksman R, Bhargava B, White LR, et al. Intracoronary beta radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000; 101 (16): 1895-8
31. King SB, Williams DO, Prakash C, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the Beta Energy Restenosis Trial (BERT). Circulation 1998; 97: 2025-30
32. Verin V, Popowski Y, de Bruyne B. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty: the Dose-Finding Study Group. N Engl J Med 2001; 344 (4): 243-9
33. Waksman R, Ajani AE, White L, et al. Intravascular gamma radiation for in-stent restenosis in saphenous vein bypass grafts (SVG WRIST). N Engl J Med 2002; 346 (16): 1194-9
34. Pokrajac B, Schmid R, Kirisits C, et al. Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. Radiother Oncol 2002; 63 (1): 97-102
35. Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty. Circulation 2000; 102: 2694-9
36. Urban P, Serruys P, Baumgart D, et al. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 2003; 24: 604-12
37. Serruys PW, Sianos G, van der Giessen W, et al. Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting: the beta radiation in Europe (BRIE) study. Eur Heart J 2002; 23
38. Waksman R, Bhargava B, Leon MB. Late thrombosis following intracoronary brachytherapy. Catheter Cardiovasc Interv 2000; 49 (3): 344-7
39. Waksman R, Bhargava B, Mintz GS, et al. Late total occlusion following intracoronary brachytherapy for patients with instent restenosis. J Am Coll Cardiol 2000; 36 (1): 65-8
40. Kim HS, Waksman R, Kollum M. Edge stenosis after intracoronary radiotherapy: angiographic, intravascular, and histological findings. Circulation 2001; 103 (17): 2219-20
41. Sabate M, Costa MA, Kozuma K. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 2000; 101 (21): 2467-71
42. Kim HS, Waksman R, Cottin Y, et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol 2001; 37 (4): 1026-30
43. Giap HB, Bendre DD, Huppe GB, et al. Source displacement during the cardiac cycle in coronary endovascular brachytherapy. Int J Radiat Oncol Biol Phys 2001; 49 (1): 273-7
44. Giap H, Teirstein P, Massulo V, et al. Barotrauma due to stent deployment in endovascular brachytherapy for restenosis prevention. Int J Radiat Oncol Biol Phys 2000; 47 (4): 1021-4
45. Jani S. Edge effect: dosimetric aspects & geographic miss. Fourth Annual Meeting of Radiotherapy to Reduce Restenosis; 2000 Jan 13-15; La Jolla
46. Brenner DJ, Miller RC, Hall EJ. The radiobiology of intravascular irradiation. Int J Radiat Oncol Biol Phys 1996; 36: 805-10
47. Brenner DJ, Miller RC. Long-term efficacy of intracoronary irradiation in inhibiting in-stent restenosis. Circulation 2001; 103: 1330-2
48. Waksman R, Ajani AE, White RL, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004; 109: 340-4
49. Grise MA, Massullo V, Jani S, et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002; 105: 2737-40
50. Jani SK. Gamma vs beta irradiation: which is superior? Cardiovasc Radiat Med 1999; 1 (1): 102-6
51. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80
52. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23
53. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease: the TAXUS-IV investigators . N Engl J Med 2004; 350: 221-31
54. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003; 107 (1): 24-7
55. Tanabe K, Serruys PW, Grube E, et al. TAXUS III trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow release polymer formulation. Circulation 2003; 107 (4): 559-64
56. Degertekin M, Regar E, Tanabe K, et al. Sirolimus-eluting stent for the treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 2003; 41: 184-9
57. Teirstein PS, King SB. Vascular radiation in a drug-eluting stent world: it's not over till it's over. Circulation 2003; 108: 384-5
58. Kipshidze NN, Kim HS, Iversen P, et al. Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. J Am Coll Cardiol 2002; 39: 1686-94
59. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-22
60. Hoher M, Wohrle J, Wohlfrom M, et al. Intracoronary beta-irradiation with a rhenium-188-filled balloon catheter: a randomized trial in patients with de novo and restenotic lesions. Circulation 2003; 107
61. Hang CL, Fu M, Hsieh BT, et al. Intracoronary beta-irradiation with liquid-rhenium-188: results of the Taiwan radiation in prevention of post-pure balloon angioplasty restenosis study. Chest 2003; 124: 1284-93
62. Reynen K, Kockeritz U, Kropp J, et al. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up. Int J Cardiol 2004; 95: 29-34